Download Files:
Products Details
Product Description
– Ruzotolimod is the agonist of TLR7. Ruzotolimod has the potential for the research of HBV, COVID-19 or SARS-CoV-2 infection (extracted from patent WO2021130195A1)[1].
Web ID
– HY-145592
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C14H18N4O5S
References
– [1]Qingyan BO, et al. Method of treating virus infection using a tlr7 agonist. Patent WO2021130195A1.
CAS Number
– 1948241-60-8
Molecular Weight
– 354.38
SMILES
– O=C1N([C@]([C@@H](C2)O)([H])O[C@]2([H])[C@H](CC)OC(C)=O)C3=NC(N)=NC=C3S1
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Toll-like Receptor (TLR)
Pathway
– Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
